Trisarga Naturals Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 06-07-2024
- Paid Up Capital ₹ 1.00 M
as on 06-07-2024
- Company Age 4 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
About Trisarga Naturals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Arun Biswas, Satish Singh, and Sarika Dandona serve as directors at the Company.
- CIN/LLPIN
U85300DL2020PTC370716
- Company No.
370716
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Sep 2020
- Date of AGM
27 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
West Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Trisarga Naturals?
Board Members(3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sarika Dandona | Director | 30-Sep-2020 | Current |
Arun Biswas | Director | 21-Oct-2020 | Current |
Satish Singh | Director | 30-Sep-2020 | Current |
Financial Performance of Trisarga Naturals.
Trisarga Naturals Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
What is the Ownership and Shareholding Structure of Trisarga Naturals?
Unlock access to Trisarga Naturals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Kyra Healthcare Consulting Private LimitedActive 13 years 9 months
Satish Singh and Sarika Dandona are mutual person
- Kyra Healthcare Startups LlpActive 8 years 11 months
Satish Singh and Sarika Dandona are mutual person
- Trisarga Health And Wellness Private LimitedActive 4 years 3 months
Satish Singh and Sarika Dandona are mutual person
- Kyra Health & Wellness Private LimitedActive 12 years 3 months
Satish Singh and Sarika Dandona are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Trisarga Naturals?
Trisarga Naturals has a workforce of 0 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Trisarga Naturals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Trisarga Naturals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.